Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant glioma.

Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant glioma. Semin Immunol. 2008 Oct; 20(5):267-75.

View in: PubMed